Synopsis
Synopsis
0
KDMF
0
VMF
0
Europe
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Pregna-1,4-diene-3,20-dione, 11,17-dihydroxy-21-(phosphonooxy)-, Disodium Salt, (11.beta.)-
2. Schembl1650407
3. Akos025394281
4. Ft-0631728
Molecular Weight | 484.4 g/mol |
---|---|
Molecular Formula | C21H27Na2O8P |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 3 |
Exact Mass | 484.12389338 g/mol |
Monoisotopic Mass | 484.12389338 g/mol |
Topological Polar Surface Area | 147 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 878 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 7 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Prednisolone sodium phosphate |
Active Ingredient | Prednisolone sodium phosphate |
Dosage Form | Solution/drops; Tablet, orally disintegrating; Solution |
Route | Ophthalmic; Oral |
Strength | eq 15mg base/5ml; eq 5mg base/5ml; eq 25mg base/5ml; eq 15mg base; eq 10mg base/5ml; eq 20mg base/5ml; eq 30mg base; eq 0.9% phosphate; eq 10mg base |
Market Status | Prescription |
Company | Mylan Pharms; Amneal Pharms; Wockhardt; Pharm Assoc; Mission Pharma; Hi Tech Pharma; Paddock; Vintage; Bausch And Lomb |
2 of 2 | |
---|---|
Drug Name | Prednisolone sodium phosphate |
Active Ingredient | Prednisolone sodium phosphate |
Dosage Form | Solution/drops; Tablet, orally disintegrating; Solution |
Route | Ophthalmic; Oral |
Strength | eq 15mg base/5ml; eq 5mg base/5ml; eq 25mg base/5ml; eq 15mg base; eq 10mg base/5ml; eq 20mg base/5ml; eq 30mg base; eq 0.9% phosphate; eq 10mg base |
Market Status | Prescription |
Company | Mylan Pharms; Amneal Pharms; Wockhardt; Pharm Assoc; Mission Pharma; Hi Tech Pharma; Paddock; Vintage; Bausch And Lomb |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
59
PharmaCompass offers a list of Prednisolone Sodium Phosphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Prednisolone Sodium Phosphate manufacturer or Prednisolone Sodium Phosphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Prednisolone Sodium Phosphate manufacturer or Prednisolone Sodium Phosphate supplier.
PharmaCompass also assists you with knowing the Prednisolone Sodium Phosphate API Price utilized in the formulation of products. Prednisolone Sodium Phosphate API Price is not always fixed or binding as the Prednisolone Sodium Phosphate Price is obtained through a variety of data sources. The Prednisolone Sodium Phosphate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sodium prednisolone phosphate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium prednisolone phosphate, including repackagers and relabelers. The FDA regulates Sodium prednisolone phosphate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium prednisolone phosphate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sodium prednisolone phosphate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sodium prednisolone phosphate supplier is an individual or a company that provides Sodium prednisolone phosphate active pharmaceutical ingredient (API) or Sodium prednisolone phosphate finished formulations upon request. The Sodium prednisolone phosphate suppliers may include Sodium prednisolone phosphate API manufacturers, exporters, distributors and traders.
click here to find a list of Sodium prednisolone phosphate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sodium prednisolone phosphate DMF (Drug Master File) is a document detailing the whole manufacturing process of Sodium prednisolone phosphate active pharmaceutical ingredient (API) in detail. Different forms of Sodium prednisolone phosphate DMFs exist exist since differing nations have different regulations, such as Sodium prednisolone phosphate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sodium prednisolone phosphate DMF submitted to regulatory agencies in the US is known as a USDMF. Sodium prednisolone phosphate USDMF includes data on Sodium prednisolone phosphate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sodium prednisolone phosphate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sodium prednisolone phosphate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Sodium prednisolone phosphate Drug Master File in Japan (Sodium prednisolone phosphate JDMF) empowers Sodium prednisolone phosphate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Sodium prednisolone phosphate JDMF during the approval evaluation for pharmaceutical products. At the time of Sodium prednisolone phosphate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Sodium prednisolone phosphate suppliers with JDMF on PharmaCompass.
A Sodium prednisolone phosphate CEP of the European Pharmacopoeia monograph is often referred to as a Sodium prednisolone phosphate Certificate of Suitability (COS). The purpose of a Sodium prednisolone phosphate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Sodium prednisolone phosphate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Sodium prednisolone phosphate to their clients by showing that a Sodium prednisolone phosphate CEP has been issued for it. The manufacturer submits a Sodium prednisolone phosphate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Sodium prednisolone phosphate CEP holder for the record. Additionally, the data presented in the Sodium prednisolone phosphate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Sodium prednisolone phosphate DMF.
A Sodium prednisolone phosphate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Sodium prednisolone phosphate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Sodium prednisolone phosphate suppliers with CEP (COS) on PharmaCompass.
A Sodium prednisolone phosphate written confirmation (Sodium prednisolone phosphate WC) is an official document issued by a regulatory agency to a Sodium prednisolone phosphate manufacturer, verifying that the manufacturing facility of a Sodium prednisolone phosphate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Sodium prednisolone phosphate APIs or Sodium prednisolone phosphate finished pharmaceutical products to another nation, regulatory agencies frequently require a Sodium prednisolone phosphate WC (written confirmation) as part of the regulatory process.
click here to find a list of Sodium prednisolone phosphate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sodium prednisolone phosphate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sodium prednisolone phosphate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sodium prednisolone phosphate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sodium prednisolone phosphate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sodium prednisolone phosphate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sodium prednisolone phosphate suppliers with NDC on PharmaCompass.
Sodium prednisolone phosphate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium prednisolone phosphate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium prednisolone phosphate GMP manufacturer or Sodium prednisolone phosphate GMP API supplier for your needs.
A Sodium prednisolone phosphate CoA (Certificate of Analysis) is a formal document that attests to Sodium prednisolone phosphate's compliance with Sodium prednisolone phosphate specifications and serves as a tool for batch-level quality control.
Sodium prednisolone phosphate CoA mostly includes findings from lab analyses of a specific batch. For each Sodium prednisolone phosphate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium prednisolone phosphate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium prednisolone phosphate EP), Sodium prednisolone phosphate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium prednisolone phosphate USP).